TRMT10C
Basic information
Region (hg38): 3:101561868-101566446
Previous symbols: [ "RG9MTD1" ]
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation defect type 30 (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation defect type 30 (Limited), mode of inheritance: AR
- combined oxidative phosphorylation defect type 30 (Limited), mode of inheritance: Unknown
- mitochondrial disease (Moderate), mode of inheritance: AR
- combined oxidative phosphorylation defect type 30 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Combined oxidative phosphorylation deficiency 30 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Neurologic | 27132592 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (43 variants)
- not_provided (36 variants)
- TRMT10C-related_disorder (5 variants)
- Combined_oxidative_phosphorylation_defect_type_30 (4 variants)
- Mitochondrial_disease (2 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRMT10C gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017819.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 13 | ||||
| missense | 57 | 64 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 2 | 57 | 18 | 0 |
Highest pathogenic variant AF is 0.000121486046
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TRMT10C | protein_coding | protein_coding | ENST00000309922 | 1 | 4585 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000971 | 0.813 | 124756 | 0 | 34 | 124790 | 0.000136 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.769 | 174 | 205 | 0.849 | 0.00000964 | 2685 |
| Missense in Polyphen | 41 | 65.029 | 0.63049 | 856 | ||
| Synonymous | 0.394 | 66 | 70.2 | 0.940 | 0.00000325 | 721 |
| Loss of Function | 1.22 | 8 | 12.7 | 0.631 | 7.36e-7 | 180 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000349 | 0.000349 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000223 | 0.000223 |
| Finnish | 0.0000928 | 0.0000928 |
| European (Non-Finnish) | 0.000115 | 0.000115 |
| Middle Eastern | 0.000223 | 0.000223 |
| South Asian | 0.000230 | 0.000229 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial tRNA N(1)-methyltransferase involved in mitochondrial tRNA maturation (PubMed:18984158, PubMed:21593607, PubMed:23042678, PubMed:27132592). Component of mitochondrial ribonuclease P, a complex composed of TRMT10C/MRPP1, HSD17B10/MRPP2 and MRPP3, which cleaves tRNA molecules in their 5'-ends (PubMed:18984158). Together with HSD17B10/MRPP2, forms a subcomplex of the mitochondrial ribonuclease P, named MRPP1-MRPP2 subcomplex, which displays functions that are independent of the ribonuclease P activity (PubMed:23042678, PubMed:29040705). The MRPP1-MRPP2 subcomplex catalyzes the formation of N(1)- methylguanine and N(1)-methyladenine at position 9 (m1G9 and m1A9, respectively) in tRNAs; TRMT10C/MRPP1 acting as the catalytic N(1)-methyltransferase subunit (PubMed:23042678). The MRPP1-MRPP2 subcomplex also acts as a tRNA maturation platform: following 5'- end cleavage by the mitochondrial ribonuclease P complex, the MRPP1-MRPP2 subcomplex enhances the efficiency of 3'-processing catalyzed by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the mitochondrial CCA tRNA nucleotidyltransferase TRNT1 enzyme (PubMed:29040705). In addition to tRNA N(1)-methyltransferase activity, TRMT10C/MRPP1 also acts as a mRNA N(1)-methyltransferase by mediating methylation of adenosine residues at the N(1) position of MT-ND5 mRNA (PubMed:29072297). {ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:21593607, ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:27132592, ECO:0000269|PubMed:29040705, ECO:0000269|PubMed:29072297}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 30 (COXPD30) [MIM:616974]: An autosomal recessive, severe mitochondrial disease characterized by lactic acidosis, hypotonia, feeding difficulties, deafness, and respiratory failure with fatal issue. Patient skeletal muscle cells show decreased activities of mitochondrial complexes I, III and IV. {ECO:0000269|PubMed:27132592}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- tRNA processing;tRNA modification in the mitochondrion;Metabolism of RNA
(Consensus)
Recessive Scores
- pRec
- 0.0631
Intolerance Scores
- loftool
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 76.81
Haploinsufficiency Scores
- pHI
- 0.0419
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trmt10c
- Phenotype
Gene ontology
- Biological process
- mitochondrial RNA 5'-end processing;tRNA methylation;positive regulation of mitochondrial translation;mRNA methylation;mitochondrial tRNA processing;mitochondrial tRNA 5'-end processing;mitochondrial tRNA 3'-end processing
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial matrix;mitochondrial ribonuclease P complex;mitochondrial nucleoid
- Molecular function
- tRNA binding;RNA binding;protein binding;tRNA (guanine-N1-)-methyltransferase activity;tRNA (adenine-N1-)-methyltransferase activity;tRNA (guanine(9)-N(1))-methyltransferase activity;mRNA (adenine-N1-)-methyltransferase activity